Folgen
Maxim Artyomov
Maxim Artyomov
Bestätigte E-Mail-Adresse bei wustl.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ...
Nature 515 (7528), 577-581, 2014
21352014
Fast gene set enrichment analysis
G Korotkevich, V Sukhov, N Budin, B Shpak, MN Artyomov, ...
biorxiv, 060012, 2016
19872016
Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization
AK Jha, SCC Huang, A Sergushichev, V Lampropoulou, Y Ivanova, ...
Immunity 42 (3), 419-430, 2015
17402015
Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation
V Lampropoulou, A Sergushichev, M Bambouskova, S Nair, EE Vincent, ...
Cell metabolism 24 (1), 158-166, 2016
11952016
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ...
Nature genetics 48 (6), 607-616, 2016
11462016
TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation
B Everts, E Amiel, SCC Huang, AM Smith, CH Chang, WY Lam, ...
Nature immunology 15 (4), 323-332, 2014
10762014
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
SCC Huang, B Everts, Y Ivanova, D O'sullivan, M Nascimento, AM Smith, ...
Nature immunology 15 (9), 846-855, 2014
10722014
TREM2 maintains microglial metabolic fitness in Alzheimer’s disease
TK Ulland, WM Song, SCC Huang, JD Ulrich, A Sergushichev, WL Beatty, ...
Cell 170 (4), 649-663. e13, 2017
9292017
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease
Y Zhou, WM Song, PS Andhey, A Swain, T Levy, KR Miller, PL Poliani, ...
Nature medicine 26 (1), 131-142, 2020
7622020
Tumor neoantigens: building a framework for personalized cancer immunotherapy
MM Gubin, MN Artyomov, ER Mardis, RD Schreiber
The Journal of clinical investigation 125 (9), 3413-3421, 2015
6942015
MHC-II neoantigens shape tumour immunity and response to immunotherapy
E Alspach, DM Lussier, AP Miceli, I Kizhvatov, M DuPage, AM Luoma, ...
Nature 574 (7780), 696-701, 2019
6752019
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
DK Sojka, B Plougastel-Douglas, L Yang, MA Pak-Wittel, MN Artyomov, ...
elife 3, e01659, 2014
5822014
Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis
M Bambouskova, L Gorvel, V Lampropoulou, A Sergushichev, ...
Nature 556 (7702), 501-504, 2018
5412018
Tissue resident CCR2− and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury
G Bajpai, A Bredemeyer, W Li, K Zaitsev, AL Koenig, I Lokshina, J Mohan, ...
Circulation research 124 (2), 263-278, 2019
5212019
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation
SE Henrickson, TR Mempel, IB Mazo, B Liu, MN Artyomov, H Zheng, ...
Nature immunology 9 (3), 282-291, 2008
5022008
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
H Mouquet, JF Scheid, MJ Zoller, M Krogsgaard, RG Ott, S Shukair, ...
Nature 467 (7315), 591-595, 2010
4892010
Itaconate: the poster child of metabolic reprogramming in macrophage function
LAJ O’Neill, MN Artyomov
Nature Reviews Immunology 19 (5), 273-281, 2019
4732019
The microbial metabolite desaminotyrosine protects from influenza through type I interferon
AL Steed, GP Christophi, GE Kaiko, L Sun, VM Goodwin, U Jain, ...
Science 357 (6350), 498-502, 2017
4642017
Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection
MT Baldridge, TJ Nice, BT McCune, CC Yokoyama, A Kambal, ...
Science 347 (6219), 266-269, 2015
4462015
TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy
M Molgora, E Esaulova, W Vermi, J Hou, Y Chen, J Luo, S Brioschi, ...
Cell 182 (4), 886-900. e17, 2020
3952020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20